Markets›GRFS

Grifols SA

GRFS
7.35
+0.15 (+2.08%)
Closing price for Sep 25, 2026 from Polygon.io

Key statistics

Previous close7.20
Open7.36
Day's range7.29 to 7.39
52-week range6.96 to 10.23
Volume507.2K
Average volume (3 months)632.5K
1-year price change-25.98%
Market value5.05B
Beta (1 year)0.89
Dividend yield1.29%

Company figures come from SEC filings. All statistics

About Grifols SA

Full profile

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Industry: Pharmaceutical Preparations · Employees: 25,247 · Headquarters: NEW YORK, NY

For learning only, not investment advice. Chart by TradingView. How to read a stock quote.